Peng Yuan

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 3

Top Topics

Metastatic Breast Cancer

Placebo Controlled

Top Venues

International journal of cancer

Cancer biology & medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Jiaxuan Liu, Maiyue He, Kaiping Ou, Xin Wang, Yipeng Wang, Liqiang Qi, Yue Chai, Mingxia Jiang, Zongbi Yi, Yang Luo, Peng Yuan, Pin Zhang, Binghe Xu, Qiao Li
Efficacy and safety of apatinib combined with dose-dense paclitaxel and carboplatin in neoadjuvant therapy for locally advanced triple-negative breast cancer: A prospective cohort study with propensity-matched analysis. International journal of cancer (2023)
Meng Xiu, Pin Zhang, Xiang Wang, Ying Fan, Qiao Li, Qing Li, Jiayu Wang, Lin Dong, Yang Luo, Peng Yuan, Zongbi Yi, Bing-He Xu
Survival outcomes for dose-dense paclitaxel plus carboplatin neoadjuvant vs standard adjuvant chemotherapy in stage II to III triple-negative breast cancer: A prospective cohort study with propensity-matched analysis. International journal of cancer 151 (4) (2022)
Anjie Zhu, Peng Yuan, Nanlin Hu, Mingzhou Li, Wenmiao Wang, Xue Wang, Jian Yue, Jiayu Wang, Yang Luo, Fei Ma, Pin Zhang, Qing Li, Binghe Xu, Shanbo Cao, Giuseppe Lippi, Yoichi Naito, Mohammed A Osman, Gustavo N Marta, Gianluca Franceschini, Armando Orlandi
Phase II study of apatinib in combination with oral vinorelbine in heavily pretreated HER2-negative metastatic breast cancer and clinical implications of monitoring ctDNA. Cancer biology & medicine (2021)